SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 June 6, 2007 ----------------------------- Date of Report (date of earliest event reported) BIOMERICA, INC. --------------- (Exact Name of Registrant as Specified in its Charter) Delaware 0-8765 95-2645573 -------- ------ ---------- (State or Other (Commission (IRS Employer Jurisdiction of File Number) Identification Number) Incorporation) 1533 Monrovia Avenue Newport Beach, California 92663 ------------------------------- (Address of Principal Executive Offices Including Zip Code) 949-645-2111 ------------ (Registrant's Telephone Number, Including Area Code) -------------- (Former Name or Former Address if Changed Since Last Report) Page 1 of 2 pages Item 8.01 Other Events - On June 6, 2007, Biomerica received income of $697,034 on the sale of Hollister-Stier Laboratories securities it held for investment. The Hollister-Stier securities were held as an option to purchase shares in Hollister-Stier Laboratories, LLC and were carried on Biomerica's balance sheet at a zero value as Hollister-Stier is a private company. The acquisition of Hollister-Stier Laboratories by Jubilant Organosys Ltd. closed on June 1, 2007. SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Dated: June 6, 2007 Biomerica, Inc. By: /s/ Zackary S. Irani ------------------------- Zackary S. Irani Chief Executive Officer